Diabetic foot infections: microbiological aspects, current and future antibiotic therapy focusing on methicillin-resistant Staphylococcus aureus.
about
Staphylococcus aureus Toxins and Diabetic Foot Ulcers: Role in Pathogenesis and Interest in DiagnosisCcpA Affects Infectivity of Staphylococcus aureus in a Hyperglycemic EnvironmentClinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria.Targeting intracellular Staphylococcus aureus to lower recurrence of orthopaedic infection.Staphylococcus aureus develops increased resistance to antibiotics by forming dynamic small colony variants during chronic osteomyelitis.Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection
P2860
Diabetic foot infections: microbiological aspects, current and future antibiotic therapy focusing on methicillin-resistant Staphylococcus aureus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Diabetic foot infections: micr ...... sistant Staphylococcus aureus.
@en
Diabetic foot infections: micr ...... sistant Staphylococcus aureus.
@nl
type
label
Diabetic foot infections: micr ...... sistant Staphylococcus aureus.
@en
Diabetic foot infections: micr ...... sistant Staphylococcus aureus.
@nl
prefLabel
Diabetic foot infections: micr ...... sistant Staphylococcus aureus.
@en
Diabetic foot infections: micr ...... sistant Staphylococcus aureus.
@nl
P2093
P2860
P1476
Diabetic foot infections: micr ...... sistant Staphylococcus aureus.
@en
P2093
Andreas Ambrosch
Edward Jude
Ralf Lobmann
Simone Haefner
P2860
P304
P356
10.1111/J.1742-481X.2011.00849.X
P577
2011-08-23T00:00:00Z